HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

MLN 8237

an aurora kinase A inhibitor
Also Known As:
MLN-8237; MLN8237; alisertib
Networked: 218 relevant articles (28 outcomes, 87 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Zhou, Xiaofei: 18 articles (01/2022 - 10/2012)
2. Venkatakrishnan, Karthik: 17 articles (01/2022 - 09/2012)
3. Ecsedy, Jeffrey A: 14 articles (01/2020 - 12/2011)
4. Ecsedy, Jeffrey: 12 articles (10/2019 - 06/2010)
5. Zhou, Shu-Feng: 10 articles (12/2017 - 01/2015)
6. El-Rifai, Wael: 9 articles (03/2022 - 03/2012)
7. Mahadevan, Daruka: 9 articles (12/2018 - 04/2011)
8. Zhou, Zhi-Wei: 8 articles (12/2017 - 01/2015)
9. He, Zhi-Xu: 8 articles (01/2017 - 01/2015)
10. Fox, Elizabeth: 6 articles (01/2022 - 09/2010)

Related Diseases

1. Neoplasms (Cancer)
2. Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
3. Neuroblastoma
4. Lymphoma (Lymphomas)
5. Glioblastoma (Glioblastoma Multiforme)

Related Drugs and Biologics

1. Aurora Kinase A
2. MLN 8237
3. Paclitaxel (Taxol)
4. Vincristine (Oncovin)
5. Phosphotransferases (Kinase)
6. Drug Combinations
7. Cyclin-Dependent Kinase 6
8. Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)
9. Carboplatin (JM8)
10. Cyclophosphamide (Cytoxan)

Related Therapies and Procedures

1. Therapeutics
2. Drug Therapy (Chemotherapy)
3. Castration
4. Induction Chemotherapy
5. Polypharmacy